ct-DNA Binding and Antibacterial Activity of Octahedral Titanium (IV) Heteroleptic (Benzoylacetone and Hydroxamic Acids) Complexes

Table 1

Zone inhibition diameter (mm) of selected titanium (IV) heteroleptic complexes (1–5) and corresponding ligands (in parentheses) against pathogenic bacterial strains.

Sr. number	Microbial species	Zone inhibition diameter (mm)
		Complex (ligand)
		() ()	() ()	() ()	() ()	() ()	Ampicillin
1	S. typhimurium	10 (9.5)	10 ()	11.5 ()	13 (11.5)	11 (9.5)	16
2	E. aerogenes	10 (9.5)	10 ()	13 ()	13 (12)	12 (10.5)	15
3	S. epidermidis	8 ()	10 (8.5)	13 (11.5)	15 (12.5)	10 (9.5)	16
4	A. faecalis	10.5 ()	11.5 (9.5)	12.5 (10.5)	10.5 (9.5)	14 (12.5)	10
5	S. aureus	10 (8.5)	10.5 (9.5)	10 (8.5)	15 (12.5)	16 (12.5)	12
6	M. luteus	11 (9.5)	10 ()	10.5 (9.5)	16.5 (13.5)	10 (8.5)	10
7	A. hydrophila	12 (10.5)	18 (13.5)	12 (10.5)	12 (10.5)	12 ()	13
8	K. pneumoniae	11 (9.5)	14 (12.5)	10 (8.5)	12 (10.5)	10 ()	11
9	P. aeruginosa	12 ()	12 (10.5)	16 (14.5)	12 (10.5)	17 (15.5)	8
10	S. sonnei	13.5 (11.5)	7.5 ()	14.5 (12.5)	11 (9.5)	8 (7.5)	13

Benzohydroxamic acid (), salicylhydroxamic acid (), acetohydroxamic acid (), hydroxyurea (), and N-benzoyl-N-phenyl hydroxylamine ().